Skip to main content
Journal cover image

Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue.

Publication ,  Journal Article
Samms, RJ; Zhang, G; He, W; Ilkayeva, O; Droz, BA; Bauer, SM; Stutsman, C; Pirro, V; Collins, KA; Furber, EC; Coskun, T; Sloop, KW ...
Published in: Mol Metab
October 2022

OBJECTIVES: Tirzepatide, a dual GIP and GLP-1 receptor agonist, delivered superior glycemic control and weight loss compared to selective GLP-1 receptor (GLP-1R) agonism in patients with type 2 diabetes (T2D). These results have fueled mechanistic studies focused on understanding how tirzepatide achieves its therapeutic efficacy. Recently, we found that treatment with tirzepatide improves insulin sensitivity in humans with T2D and obese mice in concert with a reduction in circulating levels of branched-chain amino (BCAAs) and keto (BCKAs) acids, metabolites associated with development of systemic insulin resistance (IR) and T2D. Importantly, these systemic effects were found to be coupled to increased expression of BCAA catabolic genes in thermogenic brown adipose tissue (BAT) in mice. These findings led us to hypothesize that tirzepatide may lower circulating BCAAs/BCKAs by promoting their catabolism in BAT. METHODS: To address this question, we utilized a murine model of diet-induced obesity and employed stable-isotope tracer studies in combination with metabolomic analyses in BAT and other tissues. RESULTS: Treatment with tirzepatide stimulated catabolism of BCAAs/BCKAs in BAT, as demonstrated by increased labeling of BCKA-derived metabolites, and increases in levels of byproducts of BCAA breakdown, including glutamate, alanine, and 3-hydroxyisobutyric acid (3-HIB). Further, chronic administration of tirzepatide increased levels of multiple amino acids in BAT that have previously been shown to be elevated in response to cold exposure. Finally, chronic treatment with tirzepatide led to a substantial increase in several TCA cycle intermediates (α-ketoglutarate, fumarate, and malate) in BAT. CONCLUSIONS: These findings suggest that tirzepatide induces a thermogenic-like amino acid profile in BAT, an effect that may account for reduced systemic levels of BCAAs in obese IR mice.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Mol Metab

DOI

EISSN

2212-8778

Publication Date

October 2022

Volume

64

Start / End Page

101550

Location

Germany

Related Subject Headings

  • Mice, Obese
  • Mice
  • Insulin Resistance
  • Humans
  • Glucagon-Like Peptide-1 Receptor
  • Gastric Inhibitory Polypeptide
  • Diabetes Mellitus, Type 2
  • Animals
  • Amino Acids, Branched-Chain
  • Adipose Tissue, Brown
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Samms, R. J., Zhang, G., He, W., Ilkayeva, O., Droz, B. A., Bauer, S. M., … Newgard, C. B. (2022). Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue. Mol Metab, 64, 101550. https://doi.org/10.1016/j.molmet.2022.101550
Samms, Ricardo J., GuoFang Zhang, Wentao He, Olga Ilkayeva, Brian A. Droz, Steven M. Bauer, Cynthia Stutsman, et al. “Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue.Mol Metab 64 (October 2022): 101550. https://doi.org/10.1016/j.molmet.2022.101550.
Samms RJ, Zhang G, He W, Ilkayeva O, Droz BA, Bauer SM, et al. Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue. Mol Metab. 2022 Oct;64:101550.
Samms, Ricardo J., et al. “Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue.Mol Metab, vol. 64, Oct. 2022, p. 101550. Pubmed, doi:10.1016/j.molmet.2022.101550.
Samms RJ, Zhang G, He W, Ilkayeva O, Droz BA, Bauer SM, Stutsman C, Pirro V, Collins KA, Furber EC, Coskun T, Sloop KW, Brozinick JT, Newgard CB. Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue. Mol Metab. 2022 Oct;64:101550.
Journal cover image

Published In

Mol Metab

DOI

EISSN

2212-8778

Publication Date

October 2022

Volume

64

Start / End Page

101550

Location

Germany

Related Subject Headings

  • Mice, Obese
  • Mice
  • Insulin Resistance
  • Humans
  • Glucagon-Like Peptide-1 Receptor
  • Gastric Inhibitory Polypeptide
  • Diabetes Mellitus, Type 2
  • Animals
  • Amino Acids, Branched-Chain
  • Adipose Tissue, Brown